Combined chemoimmunotherapy of patients with mature B-cell non-Hodgkin lymphomas age group until 18 years: results of multicenter study NHL 2004 m with rituximab and modified B-NHL BFM 90 protocol applications

Combined chemoimmunotherapy of patients with mature B-cell non-Hodgkin lymphomas age group until 18 years: results of multicenter study NHL 2004 m with rituximab and modified B-NHL BFM 90 protocol applications

Therapy results of 61 patients (children and adolescents, 2—17 years of age; a median — 8.76 years) with B-cells non-Hodgkin lymphomas III—IV stage and B-cell acute leukemia (B-NHL/B-ALL), treating according to protocol with polichemotherapy and monoclonal antibodies against B-cell receptor CD20 — r...

Full description

Saved in:
Bibliographic Details
Main Authors: E. V. Samochatova, L. N. Schelikhova, M. B. Belogurova, A. V. Schamardina, E. V. Bascharova, D. V. Litvinov, N. V. Myakova, L. G. Fechina, O. P. Chlebnikova, E. V. Inuschkina, O. V. Riskal, P. Z. Schammasov, I. M. Yunusova, S. Yu. Umnova, D. M. Konovalov, A. G. Talalaev, J. V. Roumiantseva, A. A. Maschan
Format: Article
Language:Russian
Published: ABV-press 2022-11-01
Series:Онкогематология
Subjects:
children
non-hodgkin lymphomas
rituximab
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/766
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://oncohematology.abvpress.ru/ongm/article/view/766

Similar Items